Literature DB >> 23592146

Chronic HBV carrier's acceptance of regular surveilling program in China.

Qing Fang1,2, You-Hua Hao1, Lei Li1, Zhen-Hua Zhang1, Jun-Zhong Wang1, Ming-Fa Chen1, Jian Kang1, Dong-Liang Yang3,4.   

Abstract

Long-term compliance with regular surveillance is important for the prevention and timely management of chronic hepatitis B (CHB). However, there are no researches focusing on the compliance of hepatitis B virus infected patients in regular surveillance so far. The purpose of our study was to investigate the outpatient compliance with long-term regular surveillance in China. Data of 3257 CHB outpatients was pooled and analyzed to assess the outpatient's compliance with the long-term regular surveillance plan. In all outpatients, the non-follow-up and the follow-up group accounted for 73.2% and 26.8%, respectively. Among the follow-up outpatient's, only 48.9% received ongoing-follow-up and 51.1% were finally lost to follow-up; the median length of visiting duration was 25 months; and the predictive 1-, 2-, 3-, 4- and 5-year ongoing follow-up rate was 72.7%, 52.5%, 42.4%, 33.8%, and 26.3%, respectively. In conclusion, our survey proved that the regular long-term surveillance on Chinese chronic HBV carrier is difficult to be fully implemented. A large proportion of outpatients do not receive routine follow-up and are at risk of treatment delay due to various social reasons.

Entities:  

Mesh:

Year:  2013        PMID: 23592146     DOI: 10.1007/s11596-013-1113-z

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  20 in total

Review 1.  Hepatitis B virus infection--natural history and clinical consequences.

Authors:  Don Ganem; Alfred M Prince
Journal:  N Engl J Med       Date:  2004-03-11       Impact factor: 91.245

2.  Privatization and its discontents--the evolving Chinese health care system.

Authors:  David Blumenthal; William Hsiao
Journal:  N Engl J Med       Date:  2005-09-15       Impact factor: 91.245

3.  Hepatitis B in China.

Authors:  Jie Liu; Daiming Fan
Journal:  Lancet       Date:  2007-05-12       Impact factor: 79.321

Review 4.  EASL Clinical Practice Guidelines: management of chronic hepatitis B.

Authors: 
Journal:  J Hepatol       Date:  2008-10-29       Impact factor: 25.083

5.  Chronic hepatitis B: update 2009.

Authors:  Anna S F Lok; Brian J McMahon
Journal:  Hepatology       Date:  2009-09       Impact factor: 17.425

Review 6.  Is chronic hepatitis B being undertreated in the United States?

Authors:  C Cohen; S D Holmberg; B J McMahon; J M Block; C L Brosgart; R G Gish; W T London; T M Block
Journal:  J Viral Hepat       Date:  2010-12-08       Impact factor: 3.728

7.  Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B.

Authors:  Stephanos J Hadziyannis; Nicolaos C Tassopoulos; E Jenny Heathcote; Ting-Tsung Chang; George Kitis; Mario Rizzetto; Patrick Marcellin; Seng Gee Lim; Zachary Goodman; Jia Ma; Sarah Arterburn; Shelly Xiong; Graeme Currie; Carol L Brosgart
Journal:  N Engl J Med       Date:  2005-06-30       Impact factor: 91.245

8.  The majority of hepatitis B carriers are not on regular surveillance in Singapore.

Authors:  C T Wai; B Mak; W Chua; S G Lim
Journal:  Singapore Med J       Date:  2004-09       Impact factor: 1.858

9.  Screening and early treatment of migrants for chronic hepatitis B virus infection is cost-effective.

Authors:  Irene K Veldhuijzen; Mehlika Toy; Susan J M Hahné; G Ardine De Wit; Solko W Schalm; Robert A de Man; Jan Hendrik Richardus
Journal:  Gastroenterology       Date:  2009-10-29       Impact factor: 22.682

10.  Management of chronic hepatitis B: consensus guidelines.

Authors:  Morris Sherman; Stephen Shafran; Kelly Burak; Karen Doucette; Winnie Wong; Nigel Girgrah; Eric Yoshida; Eberhard Renner; Philip Wong; Marc Deschênes
Journal:  Can J Gastroenterol       Date:  2007-06       Impact factor: 3.522

View more
  3 in total

Review 1.  Better plans and more powerful evidence are needed in the research and treatment of chronic hepatitis B in China.

Authors:  Changtai Zhu; Yulu Gao; Lihui Jiang; Baoqiong Ding; Yongning Sun
Journal:  Int J Clin Exp Med       Date:  2015-12-15

2.  Does Pay-For-Performance Program Increase Providers Adherence to Guidelines for Managing Hepatitis B and Hepatitis C Virus Infection in Taiwan?

Authors:  Huei-Ju Chen; Nicole Huang; Long-Sheng Chen; Yiing-Jenq Chou; Chung-Pin Li; Chen-Yi Wu; Yu-Chia Chang
Journal:  PLoS One       Date:  2016-08-12       Impact factor: 3.240

3.  More than a virus: a qualitative study of the social implications of hepatitis B infection in China.

Authors:  J Wallace; M Pitts; C Liu; V Lin; B Hajarizadeh; J Richmond; S Locarnini
Journal:  Int J Equity Health       Date:  2017-08-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.